EXACT SCIENCES CORP (EXAS) Cash from Financing Activities (2010 - 2025)

Exact Sciences (EXAS) has reported Cash from Financing Activities for 16 consecutive years, with -$75.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash from Financing Activities fell 822.67% year-over-year to -$75.9 million; the TTM figure through Dec 2025 stood at -$338.1 million (down 245.81% YoY), while the FY2025 annual figure was -$338.1 million, down 245.81% from the prior year.
• Cash from Financing Activities retreated to -$75.9 million in Q4 2025 per EXAS's latest filing, from -$1.5 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $224.6 million in Q2 2024 and bottomed at -$256.2 million in Q1 2025.
• Historically, Cash from Financing Activities has averaged $6.9 million across 5 years, with a median of $1.5 million in 2022.
• Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 4784.68% — and 2025, when it tumbled 8433.34%.
• Exact Sciences' Cash from Financing Activities stood at -$12.2 million in 2021, then jumped by 182.84% to $10.1 million in 2022, then dropped by 0.65% to $10.0 million in 2023, then increased by 4.6% to $10.5 million in 2024, then sank by 822.67% to -$75.9 million in 2025.
• Business Quant data shows EXAS's Cash from Financing Activities at -$75.9 million in Q4 2025, -$1.5 million in Q3 2025, and -$4.5 million in Q2 2025.